Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Michael Yellin | Researchclopedia

Back to researchers

Michael Yellin

Celldex Therapeutics (United States)ORCID

187

Works

26,718

Citations

42

h-index

80

i10-index

Research Topics

Cancer Immunotherapy and Biomarkers Immunotherapy and Immune Responses CAR-T cell therapy research

Affiliations

University of Southern California2004–2008

Cedars-Sinai Medical Center2006–2010

National Institutes of Health2005–2006

Beth Israel Deaconess Medical Center2010–2010

University of North Carolina Health Care2020–2020

Top Works

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

F. Stephen Hodi,Steven O’Day,et al.

201015,042 citations

T-cell and B-cell Immunology

Monoclonal and Polyclonal Antibodies Research

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

Michael Weller,Nicholas Butowski,et al.

20171,087 citations

Autoimmunity Correlates With Tumor Regression in Patients With Metastatic Melanoma Treated With Anti–Cytotoxic T-Lymphocyte Antigen-4

Peter Attia,Giao Q. Phan,et al.

20051,009 citations

Enterocolitis in Patients With Cancer After Antibody Blockade of Cytotoxic T-Lymphocyte–Associated Antigen 4

Kimberly E Beck,Joseph Blansfield,et al.

2006832 citations

Prognostic Factors Related to Clinical Response in Patients with Metastatic Melanoma Treated by CTL-Associated Antigen-4 Blockade

Stephanie G. Downey,Jacob A. Klapper,et al.

2007624 citations

Tumor Regression and Autoimmunity in Patients Treated With Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Interleukin 2: A Phase I/II Study

Ajay V. Maker,Giao Q. Phan,et al.

2005489 citations

Phase I/II Study of Ipilimumab for Patients With Metastatic Melanoma

Jeffrey S. Weber,Steven O’Day,et al.

2008460 citations

Autoimmunity in a Phase I Trial of a Fully Human Anti-Cytotoxic T-Lymphocyte Antigen-4 Monoclonal Antibody With Multiple Melanoma Peptides and Montanide ISA 51 for Patients With Resected Stages III and IV Melanoma

Kristin M. Sanderson,Ronald Scotland,et al.

2004433 citations

Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination

Linda Hammerich,Thomas U. Marron,et al.

2019427 citations